April 2026
The global pulmonary embolism market size is estimated to hit around USD 2.70 billion by 2035 increasing from USD 6.04 billion in 2025, with a CAGR of 8.38%.
March 2026
The global pulmonary arterial hypertension market size is expected to increase to USD 13.50 billion by 2034 from USD 8.48 billion in 2025 with a CAGR of 5.30%.
December 2025
The chronic obstructive pulmonary disease treatment market size is expected to hit around USD 33.03 billion by 2035 from USD 21.04 billion in 2025 at a CAGR of 5.14%.
August 2025
The global pulmonary alveolar proteinosis (PAP) drugs market size was evaluated at USD 750.05 million in 2024 and is predicted to hit around USD 1,478.22 million by 2034, growing at a CAGR of 7.02%.
January 2025
The global pulmonary drug delivery systems market size is projected to hit around USD 87.73 billion by 2034 from USD 55.74 billion in 2024 with a CAGR of 4.64%.